Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    Hypericin
Show Display Options
Rank Status Study
1 Completed A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
Condition: HIV Infections
Intervention: Drug: Hypericin
2 Recruiting FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Condition: Cutaneous T-Cell Lymphoma
Interventions: Drug: SGX301 (synthetic hypericin);   Drug: Placebo
3 Completed A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Hypericin
4 Not yet recruiting Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis
Condition: Peritoneal Carcinomatosis
Interventions: Drug: St. John's Wort;   Device: Photodynamic diagnostic and therapy

Study has passed its completion date and status has not been verified in more than two years.